Financials
Financial year 2025
MEDIDEVS from Grobbendonk, company number BE0753600819, closed financial year 2025 with a result of € 46,440 after tax. For that financial year MEDIDEVS recorded a gross margin of € 105,663 and equity of € 92,443. Compared with financial year 2024, the result moved from € 31,635 to € 46,440. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ 92,443
▼ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 46,440
▲ 47% vs 2024
Profit after tax over the fiscal year.
€ 23,893
▼ 62% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 59,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 23,224
▲ 39% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,244
▼ 7% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 5,815
▲ 81% vs 2024
Loans from banks and other lenders, long and short.
€ 1,472
▼ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,929
▲ 22% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 69,235 | € 130,754 | € 73,810 | € 105,663 | ▲ 43% |
| Profit after taxes | € 48,336 | € 93,651 | € 31,635 | € 46,440 | ▲ 47% |
| Equity | € 58,716 | € 98,367 | € 105,002 | € 92,443 | ▼ 12% |
| Total debts | € 34,915 | € 53,892 | € 18,507 | € 26,887 | ▲ 45% |
| Cash | € 25,325 | € 91,200 | € 62,195 | € 23,893 | ▼ 62% |
| Retained profit | € 48,716 | € 88,367 | € 95,002 | € 82,443 | ▼ 13% |
| Dividend | € 14,000 | € 54,000 | € 25,000 | € 59,000 | ▲ 136% |
| Bank debt | € 12,500 | € 11,328 | € 3,215 | € 5,815 | ▲ 81% |
| Balance sheet total | € 93,632 | € 152,260 | € 123,509 | € 119,330 | ▼ 3% |
Key figures of MEDIDEVS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDIDEVS?
What happened at MEDIDEVS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 46,440 (▲ 47% vs 2024). Source: NBB ↗
- New establishment in Grobbendonk. KBO
- Start of the company according to the CBE. KBO
In short
From € 48,336 profit in 2022 to € 46,440 profit in 2025.
Paid € 74,129 in corporate taxes since 2022.
Best year ever: 2023, with € 93,651 profit.
Paid out € 152,000 in dividends to the owners in total.
Management
Behind MEDIDEVS is DIRK JOOSTENS.
Directors
According to the 2025 annual accounts
DIRK JOOSTENS
Director
Establishments
Establishment units
Physical locations of this company
Sperwerlaan 6
2280 Grobbendonk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0753.600.819
- VAT number
- BE 0753.600.819
- Registered office
- Sperwerlaan 6, 2280 Grobbendonk
- Names & denominations
- MEDIDEVS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 September 2020
- Peppol
- Active · Active since 27 Mar 2026
- Contact
- [email protected] 0468221332
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Overige dienstverlenende activiteiten op het gebied van informatie
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.